Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An activated form of ADAM10 is tumor selective and regulates cancer stem-like cells and tumor growth
Lakmali Atapattu, Nayanendu Saha, Chanly Chheang, et al.
The Journal of Experimental Medicine (2016) Vol. 213, Iss. 9, pp. 1741-1757
Open Access | Times Cited: 65

Showing 1-25 of 65 citing articles:

Triptolide and Its Derivatives as Cancer Therapies
Pawan Noel, Daniel D. Von Hoff, Ashok K. Saluja, et al.
Trends in Pharmacological Sciences (2019) Vol. 40, Iss. 5, pp. 327-341
Closed Access | Times Cited: 256
Structural Basis for Regulated Proteolysis by the α-Secretase ADAM10
T.C.M. Seegar, Lauren Killingsworth, Nayanendu Saha, et al.
Cell (2017) Vol. 171, Iss. 7, pp. 1638-1648.e7
Open Access | Times Cited: 139
Targeting ADAM10 in Cancer and Autoimmunity
Timothy M. Smith, Anuj Tharakan, Rebecca Martin
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 89
Redox signaling and metabolism in Alzheimer's disease
Mariana Holubiec, Manuela Gellert, Eva-Maria Hanschmann
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 39
Platelets in Hemostasis, Thrombosis, and Inflammation After Major Trauma
Paul Vulliamy, Paul C. Armstrong
Arteriosclerosis Thrombosis and Vascular Biology (2024) Vol. 44, Iss. 3, pp. 545-557
Open Access | Times Cited: 13
Clinical significance and inflammatory landscapes of a novel recurrence-associated immune signature in early-stage lung adenocarcinoma
Chaoqi Zhang, Zhen Zhang, Guochao Zhang, et al.
Cancer Letters (2020) Vol. 479, pp. 31-41
Closed Access | Times Cited: 65
NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells
Elia Farah, Chaohao Li, Lijun Cheng, et al.
Journal of Biological Chemistry (2019) Vol. 294, Iss. 21, pp. 8543-8554
Open Access | Times Cited: 64
ADAM proteases: Emerging role and targeting of the non-catalytic domains
Nayanendu Saha, Dorothea Robev, Juha P. Himanen, et al.
Cancer Letters (2019) Vol. 467, pp. 50-57
Open Access | Times Cited: 60
LncRNA ZFAS1 confers inflammatory responses and reduces cholesterol efflux in atherosclerosis through regulating miR-654-3p-ADAM10/RAB22A axis
Xiaoqiang Tang, Ruohan Yin, Haifeng Shi, et al.
International Journal of Cardiology (2020) Vol. 315, pp. 72-80
Closed Access | Times Cited: 52
New insights into the function and pathophysiology of the ectodomain sheddase A Disintegrin And Metalloproteinase 10 (ADAM10)
David P. Rosenbaum, Paul Säftig
FEBS Journal (2023) Vol. 291, Iss. 13, pp. 2733-2766
Open Access | Times Cited: 22
A Functional Role of GAS6/TAM in Nonalcoholic Steatohepatitis Progression Implicates AXL as Therapeutic Target
Anna Tutusaus, Estefanía de Gregorio, Blanca Cucarull, et al.
Cellular and Molecular Gastroenterology and Hepatology (2019) Vol. 9, Iss. 3, pp. 349-368
Open Access | Times Cited: 53
Structural and mechanistic aspects influencing the ADAM10-mediated shedding of the prion protein
Luise Linsenmeier, Behnam Mohammadi, Sebastian Wetzel, et al.
Molecular Neurodegeneration (2018) Vol. 13, Iss. 1
Open Access | Times Cited: 52
The pleiotropic roles of ADAM9 in the biology of solid tumors
Victor O. Oria, Paul Lopatta, Oliver Schilling
Cellular and Molecular Life Sciences (2018) Vol. 75, Iss. 13, pp. 2291-2301
Open Access | Times Cited: 50
The role of proteases in epithelial-to-mesenchymal cell transitions in cancer
Julia Mitschke, Ulrike Burk, Thomas Reinheckel
Cancer and Metastasis Reviews (2019) Vol. 38, Iss. 3, pp. 431-444
Closed Access | Times Cited: 49
miR-365a-3p regulates ADAM10-JAK-STAT signaling to suppress the growth and metastasis of colorectal cancer cells
Yonggang Hong, Cheng Xin, Hao Zheng, et al.
Journal of Cancer (2020) Vol. 11, Iss. 12, pp. 3634-3644
Open Access | Times Cited: 40
MAP4K4 promotes ovarian cancer metastasis through diminishing ADAM10-dependent N-cadherin cleavage
Kelie Chen, Xiaoyu Yuan, Shengchao Wang, et al.
Oncogene (2023) Vol. 42, Iss. 18, pp. 1438-1452
Open Access | Times Cited: 13
Epigenetic Regulation of a Disintegrin and Metalloproteinase (ADAM) Transcription in Colorectal Cancer Cells: Involvement of β-Catenin, BRG1, and KDM4
Lina Sun, Baoyu Chen, Jiahao Wu, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 37
FGFR2 mutations promote endometrial cancer progression through dual engagement of EGFR and Notch signalling pathways
Garima Dixit, Jesús González Bosquet, Joseph Skurski, et al.
Clinical and Translational Medicine (2023) Vol. 13, Iss. 5
Open Access | Times Cited: 11
Combined proteomics and CRISPR‒Cas9 screens in PDX identify ADAM10 as essential for leukemia in vivo
Ehsan Bahrami, Jan Philipp Schmid, Vindi Jurinović, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 11
ADAM10 isoforms: optimizing usage of antibodies based on protein regulation, structural features, biological activity and clinical relevance to Alzheimer’s disease
Sabrina Dorta, Vanessa Alexandre-Silva, Cecília Patrícia Popolin, et al.
Ageing Research Reviews (2024) Vol. 101, pp. 102464-102464
Open Access | Times Cited: 4
Anti-SARS-CoV-2 and anticancer properties of triptolide and its derived carbonized nanomaterials
Rubina Kousar, Tahira Akhtar, Chin‐Jung Lin, et al.
Cancer Letters (2025), pp. 217677-217677
Open Access
ADAM10 Sheddase Activity is a Potential Lung-Cancer Biomarker
Toshie Yoneyama, Michael Gorry, Andrea Sobo-Vujanovic, et al.
Journal of Cancer (2018) Vol. 9, Iss. 14, pp. 2559-2570
Open Access | Times Cited: 34
The metalloproteinase ADAM10 requires its activity to sustain surface expression
Anke Seifert, Stefan Düsterhöft, Justyna Wozniak, et al.
Cellular and Molecular Life Sciences (2020) Vol. 78, Iss. 2, pp. 715-732
Open Access | Times Cited: 32
The cancer cell secretome drives cooperative manipulation of the tumour microenvironment to accelerate tumourigenesis
Shona Ritchie, Daniel A. Reed, Brooke A. Pereira, et al.
Faculty Reviews (2021) Vol. 10
Open Access | Times Cited: 25
Fully human monoclonal antibody targeting activated ADAM10 on colorectal cancer cells
Nayanendu Saha, Du-San Baek, Rachelle Mendoza, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114494-114494
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top